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ABSTRACT 1 
Purpose:  To examine associations between retinal vessel morphometry and 2 
cardiometabolic risk factors in older British men and women. 3 
Design:  Retinal imaging examination as part of the European Prospective Investigation into 4 
Cancer-Norfolk Eye study. 5 
Participants:  7411 participants underwent retinal imaging and clinical assessment.  Retinal 6 
images were analysed using a fully automated validated computerised system, which 7 
provides novel measures of vessel morphometry. 8 
Methods:  Associations between cardiometabolic risk factors, chronic disease and retinal 9 
markers were analyzed using multi-level linear regression, adjusted for age, sex and within 10 
person clustering, to provide percentage differences in tortuosity and absolute differences 11 
in width. 12 
Main outcomes measures:  Retinal arteriolar and venular tortuosity and width. 13 
Results:  279,802 arterioles, and 285,791 venules from 5947 participants (mean age 67.6 14 
years, SD 7.6, 57% female) were analysed.  Increased venular tortuosity was associated with 15 
higher BMI (2.5%, 95% CI 1.7,3.3% per 5 kg/m²) and HbA1c (2.2%, 95%CI 1.0,3.5% per %), 16 
and with prevalent type 2 diabetes (6.5%, 95%CI 2.8,10.4%); wider venules were associated 17 
with older age (2.6m, 95%CI 2.2,2.9m per decade), higher triglycerides (0.6µm, 95%CI 18 
0.3,0.9µm per mmol/L), BMI (0.7m, 95%CI 0.4,1.0 per 5 kg/m²) and HbA1c (0.4µm, 95%CI -19 
0.1,0.9 per %) and being a current smoker (3.0m, 95%CI 1.7,4.3m); similarly smoking was 20 
also associated with wider arterioles (2.1m, 95%CI 1.3,2.9m).  Thinner venules were 21 
associated with HDL (1.4m, 95%CI 0.7,2.2 per mmol/L).  Arteriolar tortuosity increased 22 
with age (5.4%, 95%CI 3.8,7.1% per decade), higher systolic blood pressure (1.2%, 95%CI 23 
0.5,1.9% per 10mmHg), in females (3.8, 95%CI 1.4,6.4%) and with prevalent stroke (8.3%, 24 
4 
95%CI -0.6,18%); no association was observed with prevalent myocardial infarction.  25 
Narrower arterioles were associated with age (0.8m, 95%CI 0.6,1.0m per decade), higher 26 
systolic blood pressure (0.5m, 95%CI 0.4,0.6m per 10mmHg), total cholesterol (0.2m, 27 
95%CI 0.0,0.3m per mmol/L) and HDL (1.2m, 95%CI 0.7,1.6m per mmol/L).   28 
Conclusions:  Metabolic risk factors show a graded association with both tortuosity and 29 
width of retinal venules, even among people without clinical diabetes, whereas 30 
atherosclerotic risk factors correlate more closely with arteriolar width, even excluding 31 
those with hypertension and cardiovascular disease. These non-invasive microvasculature 32 
measures should be evaluated further as predictors of future cardiometabolic disease 33 
among apparently healthy individuals. 34 
Keywords:  Retinal vessels, morphology, cardiometabolic risk factors 35 
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Cardiovascular disease (CVD), including coronary heart disease (CHD), heart failure and 36 
stroke, is responsible for a substantial burden of morbidity and disability.1  Type 2 diabetes 37 
is an increasing public health problem, affecting 1 in 10 adults globally, and a major cause of 38 
premature death and morbidities, especially CVD.2  Early detection and prevention both of 39 
CVD and Type 2 diabetes is key to limiting future morbidity and mortality.3;4  While disease 40 
risk factors for Type 2 diabetes, such as blood glucose levels and HbA1c, are yet to show 41 
good screening performance,5 established markers of early vascular disease are used in risk 42 
prediction models to estimate future risk of CVD, providing indications for medical / lifestyle 43 
interventions to alter disease trajectory.6;7  There have been a number of attempts to 44 
improve the performance of these risk prediction models, by adding other risk factors.6;745 
However, the addition of novel risk factors have added little to CHD prediction.8  Recent 46 
evidence suggests that early markers for the presence of vascular disease (as opposed to 47 
additional risk factors) are needed to improve risk prediction for population screening.5;948 
49 
Detailed retinal vasculometry may offer such a marker.  Growing evidence suggests that 50 
morphological features in retinal vessels, in particular vessel width, are early physiological 51 
markers of cardiometabolic risk and disease (as well as other disease processes).10-13  While 52 
strong evidence has accrued for some of these associations, particularly associations with 53 
Type 2 diabetes and CVD (and their related risk factors), other associations have remained 54 
inconsistent.  For instance, wider arterioles have been associated with higher levels of blood 55 
glucose, total cholesterol, triglycerides and inflammatory markers, but not in all studies.10;1256 
Similarly associations of venular width with blood pressure have also been inconclusive,1057 
although recent evidence suggests increased width associated with hypertension.14  Wider 58 
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venules also seem to be associated with diabetes, elevated glycosylated haemoglobin, lower 59 
levels of high density lipoprotein, inflammatory markers, smoking and obesity.10-1260 
However, some inconsistencies in the presence or absence of these associations (perhaps 61 
due to uncertainty caused by sample size) remain.11;12  Moreover, in comparison to studies 62 
examining vessel width, associations with vessel tortuosity have been little studied,1563 
especially in relation to metabolic markers, and may provide further insight into 64 
vasculometry changes associated with cardiometabolic risk.  Large population studies are 65 
needed to resolve these uncertainties, and to allow the comparative performance of width 66 
and tortuosity associations to be gauged.  However, the assessment of retinal vessel 67 
morphometry from retinal images, even with computerized assistance, has so far been 68 
heavily reliant on subjective operator involvement, which is time consuming and open to 69 
measurement error,16 limiting its use in large scale, preventative initiatives in a community 70 
setting.  We have developed a fully automated system for examining retinal vessel size and 71 
tortuosity, which overcomes many of these difficulties.17-19  We have used this system to 72 
examine the associations between cardiometabolic risk factors and retinal vascular 73 
characteristics in a large prospective population study of older British men and women, to 74 
confirm associations previously reported with vessel width, but to provide novel 75 
associations with measures of vessel tortuosity. 76 
7 
RESEARCH DESIGN AND METHODS 77 
Study Population:-  The European Prospective Investigation into Cancer (EPIC) study is a 78 
European based prospective cohort study designed to investigate the aetiology of major 79 
chronic diseases.20  The UK component of the study, EPIC-Norfolk, recruited from general 80 
practices in and around the city of Norfolk, and examined 25,639 participants (99.7% white 81 
European) aged 40 to 79 at baseline, between 1993 and 1997 (response rate 33%).21;2282 
Study participants had a detailed examination (including anthropometry, blood pressure, 83 
urine and venous blood sampling) and questionnaire assessment at entry (including 84 
information on pre-existing cardiovascular disease, type 2 diabetes and other medical 85 
conditions), and completed periodic questionnaires about their health (with a particular 86 
focus on dietary habits).  Participants have been followed up over a 13-year period for 87 
morbidity and mortality.  In addition to questionnaire data, participants were invited for 88 
further clinical examinations over this period, including repeat anthropometric assessment, 89 
venous blood sampling, retinal imaging, and physiological measures.2290 
91 
Third Follow-Up:  Between 2004 and 2011, 8623 participants provided updated information 92 
on medical history and lifestyle behaviour.22 Weight and height, were measured with 93 
participants in light clothing without shoes.  Weight was measured to the last 0.1 kg using 94 
regularly calibrated digital scales (Tanita TBF-300, Tanita UK Ltd, Middlesex, UK), and height 95 
to the last complete 0.1 cm using a stadiometer (Chasmors, UK).  Body mass index (BMI) was 96 
calculated as weight / height squared in kg/m².  Seated blood pressure was measured twice 97 
using an automated blood pressure monitor (Accutorr PlusTM, Datascope Patinet 98 
Monitoring, Huntington, UK); the mean of both measures was used.  A non-fasting venous 99 
blood sample was collected; details of the analytic measures have been published 100 
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previously.22  HbA1c was measured in whole blood using high performance liquid 101 
chromatography. Serum total cholesterol and HDL-cholesterol were measured using an 102 
auto-analyser (RA 1000 Technicon, Bayer Diagnostics, Basingstoke, UK).  LDL-cholesterol was 103 
calculated using the Fredrickson–Friedewald equation.23104 
105 
Ocular Examination:  Ocular assessment included measurement of vision, visual acuity 106 
(LogMAR acuity) and closed field auto-refraction (Humphrey model 500, Humphrey 107 
Instruments, San Leandro, California, USA).  Macular centred 45º digital fundus photographs 108 
were taken using a TRC-NW6S non-mydriatic retinal camera and IMAGEnet Telemedicine 109 
System (Topcon Corporation, Tokyo, Japan) with a 10 megapixel Nikon D80 camera (Nikon 110 
Corporation, Tokyo, Japan) without pharmacological dilation of the pupil.  Image processing 111 
was carried out using an automated computerised system (QUARTZ).17-19  The automated 112 
system distinguishes between right and left eyes (by optic disc localisation), venules and 113 
arterioles, identifies vessel segments, out-puts centreline coordinates, and measures vessel 114 
width and angular change between vessel centreline coordinates, as well as providing 115 
further measures of tortuosity.17-19;24  An ensemble classifier of bagged decision trees (with 116 
colour information) was used to classify vessels as being either venules or arterioles.  Only 117 
vessels which were classified with 80% or more probability were retained, to balance the 118 
number of venules and arterioles detected, as well as maximise the number of vessels 119 
included for analyses.18  The performance of the Arteriole/Venule (A/V) detection program 120 
was manually verified in a sub-set of images, and had detection rates of 84% for arterioles 121 
and 77% for venules, and corresponding false positive rates of 23% and 16% respectively.18122 
An automated assessment of image quality was also made based on the segmented 123 
vasculature.18  The system obtains thousands of measures of width and tortuosity from the 124 
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whole retinal image (dependent on image quality), not just concentric areas centred on the 125 
disc.10  These measures were summarised using mean width in microns and tortuosity with 126 
arbitrary units, weighted by segment length, for arterioles and venules separately for each 127 
image. In the case of multiple images per person, an automated algorithm developed to 128 
assess image quality allowed the best right eye and best left eye images to be selected for 129 
analyses.  A previously validated tortuosity measure which shows good agreement with 130 
subjective assessment of vessel tortuosity, based on the mean change in chord length 131 
between successive divisions of the vessel was used.24  System performance has been 132 
outlined in detail and validated previously, and allows automated batch processing of 133 
images from large population based studies.17-19  A model eye was used to quantify the 134 
magnification characteristics of the telecentric fundus camera used (Topcon TRC-NW6S), 135 
allowing pixel dimensions of vessel width to be converted to real size.25136 
137 
Ethics, Governance and Consent:  The EPIC-Norfolk Eye Study was carried out following the 138 
principles of the Declaration of Helsinki and the Research Governance Framework for Health 139 
and Social Care. The study was approved by the Norfolk Local Research Ethics Committee 140 
(05/Q0101/191) and East Norfolk and Waveney NHS Research Governance Committee 141 
(2005EC07L). All participants gave written, informed consent. 142 
143 
Statistical Analysis:  Statistical analyses were carried out using STATA software (version 13, 144 
StataCorp LP, College Station, TX).  Segment wise weighted mean widths and tortuosity 145 
were used, to provide a measure for venules and arterioles separately, for each eye.  146 
Histograms of retinal vessel widths showed normal distributions, while measures of 147 
tortuosity were positively skewed and log-transformed.  Multilevel linear regression models 148 
10 
adjusting for age and sex were used to examine associations of cardiometabolic risk factors 149 
and prevalent disease status to retinal vessel morphometry outcomes, allowing for repeated 150 
measures of vessel indices within the same person.  Regression models provided mean 151 
differences in width and percentage differences in tortuosity for venules and arterioles 152 
separately, per decade in age, females versus males, current smokers and former smokers 153 
versus never-smokers, or per unit increase in cardiometabolic risk factor (per 5 kg/m² 154 
increase in BMI, per 10 mmHg in systolic and diastolic blood pressure, per mmol/L increase 155 
in total cholesterol, high density lipoprotein, triglyceride, and per percentage rise in HbA1c).  156 
For disease outcomes, differences in vessel indices were obtained comparing those with 157 
prevalent disease present (including type 2 diabetes, MI, stroke, and known / treated 158 
hypertension) versus absent. Differences in associations between men and women were 159 
formally examined by inclusion of an interaction term between the risk factor and sex into 160 
the regression model. Risk factors found to be statistically significantly related to vascular 161 
measures at the 5% level were subsequently included in mutually adjusted models. We also 162 
examined associations after exclusion of participants with prevalent disease outcomes. 163 
11 
RESULTS 164 
Of 18,380 individuals invited to participate in this phase of the study, 8,623 (47%) took part 165 
(mean age 67.6 years, 57% female).  Supplemental Figure 1 shows a flow diagram of the 166 
numbers participating in the study.  Fundus imaging and refractive assessment were carried 167 
out in 7411 individuals, of whom 5,957 participants (80%) had at least one image of 168 
sufficient quality and classified vessels as arterioles or venules with a probability set at 80% 169 
detection.  It was not possible to obtain useful data from the remainder as images were 170 
miscentred, defocussed, or were obstructed by lashes and/or media opacities.  A small 171 
number had missing data for height, weight or blood pressure (n=10), leaving 5947 172 
participants with measures of vessel width and tortuosity for 565,593 vessel segments 173 
(279,802,arterioles, 285,791 venules) from 10,474 images; blood sample data were available 174 
for 5514.  Participant characteristics of EPIC participants at baseline, and those who took 175 
part in the third health examination with and without useable fundus images have been 176 
described previously.26  Those attending the 3rd Health Check (3HC) were younger at 177 
baseline, of higher BMI and socioeconomic status, and were less likely to be a current 178 
smoker compared to participants not followed-up.26  Participant characteristics of EPIC 179 
participants who took part in the third health examination, and who were included in the 180 
analyses compared with those who were not (5,947 versus 2,676 participants) are 181 
summarised in Table 1.  Other than those included being slightly younger (mean age 68 182 
years vs 71 years), there was no clear evidence of a systematic difference in 3HC participant 183 
characteristics.  Retinal vessel morphometry in those with useable fundus images are also 184 
summarised for arterioles and venules separately.  Histograms of arteriolar and venular 185 
width and tortuosity measures (with and without log transformation) are shown in 186 
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Supplemental Figure 2, and shows appreciable variation in these measures within this study 187 
population.   188 
189 
Differences in retinal vessel width in microns, and percentage differences in tortuosity by 190 
Type 2 diabetes and CVD risk factors and outcomes are shown by vessel type in Table 2.  191 
Arterioles were inversely associated and more tortuous with older age (0.8m, 95%CI 0.6, 192 
1.0m and 5.4%, 95%CI 3.8, 7.1% per decade respectively).  Wider venules were observed 193 
with older age (mean difference 2.6m, 95%CI 2.2,2.9m per decade), and amongst current 194 
smokers compared to never smokers (3.0m, 95%CI 1.7, 4.3m).  Narrower arterioles 195 
(0.5m, 95%CI 0.2,0.8) and more tortuous arterioles and venules were strongly associated 196 
with being female compared to male (3.8%, 95% CI 1.4, 6.4%; 2.2%, 95% CI 0.7, 3.6% 197 
respectively).   198 
Retinal vasculometry associations with metabolic risk factors:- 199 
Venular width was positively associated with Type 2 diabetes risk factors, including higher 200 
BMI (0.7m, 95%CI 0.4, 1.0m per 5 kg/m²), and HbA1c (0.4m, 95%CI -0.1, 0.9m per %).  201 
Wider venules were also positively associated with elevated levels of triglycerides (0.6m, 202 
95%CI 0.3, 0.9m per mmol/L).  Venular tortuosity was also positively associated with Type 203 
2 diabetes risk factors, as well as prevalent Type 2 diabetes.  Venules were 2.5% more 204 
tortuous (95% CI 1.7, 3.3%) per 5 kg/m² increase in BMI, 2.2% more tortuous (95% CI 1.0, 205 
3.5%) per percentage rise in HbA1c, and 6.5% more tortuous (95% CI 2.8, 10.4%) amongst 206 
those with Type 2 diabetes compared to those without.   207 
Retinal vasculometry associations with cardiovascular risk factors:- 208 
Arteriolar widths were inversely associated with age, systolic (0.5m 95%CI 0.4, 0.6m per 209 
10mmHg rise) and diastolic blood pressure (1.0m, 95%CI 0.9, 1.2m per 10mmHg rise).  210 
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Arteriolar tortuosity was also positively associated with systolic blood pressure (1.2%, 95% 211 
CI 0.5, 1.9% per 10mmHg respectively).  Arteriolar width was inversely associated with total 212 
cholesterol (0.2m, 95%CI 0.0, 0.3m per mmol/L) and HDL (1.2m, 95%CI 0.7, 1.6m per 213 
mmol/L).  Narrower venules and decreased venular tortuosity were associated with HDL 214 
cholesterol (1.4m, 95%CI 0.7, 2.1m, 1.8%, 95%CI -0.1, 3.7% less tortuosity per mmol/L).  215 
No associations were observed with prevalent MI, but there was a suggestion of increased 216 
arteriolar tortuosity with prevalent stroke (8.3%, 95%CI -0.6, 18%).  Arterioles were 217 
narrower and more tortuous with increasing age; venular width increased with age. Both 218 
vessel types were wider amongst smokers compared with lifelong never smokers. Figure 1 219 
shows the associations between retinal vessel indices and Type 2 diabetes and CVD risk 220 
factors by quintile; statistically significant associations appeared to be graded.  These 221 
associations remained after exclusion of those with prevalent disease, including MI, stroke, 222 
and diabetes (n=466).   223 
Sensitivity and multiple variable analyses:- 224 
Sensitivity analyses examined the differences in vessel width and tortuosity associated with 225 
cardiometabolic risk factors, excluding those with clinical diabetes / cardiovascular disease, 226 
and those with known / treated hypertension (data available on request).  Metabolic 227 
associations with venular width and tortuosity persist after exclusion of those with clinical 228 
diabetes, and arteriolar width associations with vascular risk factors (particularly blood 229 
pressure) remain after excluding those with cardiovascular disease and hypertension.    230 
Retinal vessel associations were similar in males and females (tests for interaction P>0.05), 231 
except for HDL, for which opposing associations with arteriolar tortuosity were apparent. 232 
Per mmol/L higher HDL, arteriolar tortuosity was 5.8% (95% CI 0.1, 11.8%) higher in men, 233 
but 4.0% (95% CI 0.0, 7.8%) lower in women (test for interaction p=0.006). 234 
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The mutual independence of these risk factor associations was also examined. Mutually 235 
adjusted risk factor associations are presented in Supplemental Table 1.  Risk factors that 236 
were statistically significantly associated with retinal vasculometry in Table 2 were included 237 
in multiple variable regression models.  Associations with both arteriolar morphometry 238 
measures and cardiometabolic risk factors remained remarkably stable.  Consistent 239 
associations were observed between arteriolar width and age, current smoking status, 240 
blood pressure and HDL cholesterol, but there was no evidence of an independent 241 
association with total cholesterol. Similarly strong associations remained for arteriolar 242 
tortuosity with age, sex and blood pressure.  Associations from mutually adjusted models 243 
for venular measures were also remarkably similar to the associations presented in Table 2.  244 
Venular width associations with age, current smoking, BMI and diastolic blood pressure 245 
were relatively unchanged, but associations with HDL cholesterol and triglycerides were 246 
attenuated towards the null.  Further investigation showed that associations with lipids 247 
were primarily confounded by BMI.  Venular tortuosity associations with sex and BMI were 248 
relatively unchanged. However, the association with HbA1c was attenuated (1.3%, 95%CI 249 
0.0,2.6%, increase in venular tortuosity per % increase in HbA1c), and the association with 250 
systolic blood pressure was weakened by adjustment for BMI.  Multilevel regression models 251 
adjusting for age, sex and blood pressure showed a stronger association with prevalent 252 
stroke than in Table 2, with 9.0% more tortuous arterioles amongst those who had suffered 253 
a stroke compare to those who had not (95%CI 0.1,18.8%, p<0.001), suggesting that the 254 
effect on arteriolar tortuosity is independent of systolic blood pressure.  Increased venular 255 
tortuosity among those with prevalent diabetes was independent of sex, BMI and blood 256 
pressure (5.5%, 95%CI 1.4%,8.9%). 257 
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DISCUSSION 258 
Our results are consistent with previously documented retinal vasculometry associations 259 
with Type 2 diabetes and CVD risk factors and outcomes,10-13 but provide further insight 260 
where uncertainties over the presence or absence of associations exist.  Moreover, novel 261 
associations with vessel tortuosity provide further evidence of vasculometry changes.  262 
Findings suggest that Type 2 diabetes risk factors and prevalent Type 2 diabetes are 263 
associated with the morphology of retinal venules, both in terms of width and tortuosity, 264 
while coronary risk factors have a greater influence on arteriolar width.  These associations 265 
remain after exclusion of those with prevalent diabetes, cardiovascular disease, and with 266 
known / treated hypertension, suggesting that these vessel changes may be indicative of 267 
preclinical phases of disease. 268 
269 
While retinal signs of diabetic eye disease are well described,27 there have been some 270 
uncertainties about the association between diabetes, particularly risk factors for Type 2 271 
diabetes, and retinal vessel morphometry, with inconsistencies between cross-sectional and 272 
longitudinal findings.28  However, a recent meta-analysis showed that wider venules, but not 273 
arterioles, were associated with diabetes;29 consistent with cross-sectional observations 274 
suggesting that wider venules are associated with increasing levels of fasting glucose and 275 
HbA1c levels.28  Findings from the present study are consistent with these risk factor 276 
observations, not only replicating the associations between increased venular width and 277 
glycosylated haemoglobin (although not formally statistically significant), but also showing 278 
coherent associations with other metabolic risk factors, including BMI, as well as novel 279 
associations with levels of triglyceride; associations which were absent with arteriolar width.  280 
The present study also showed that narrow venules were associated with increased HDL, 281 
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which when considered in relation to levels of triglyceride, might be considered as a further 282 
indicator of insulin resistance.30  However, venular width associations with HDL and 283 
triglycerides were weakened after multivariable adjustment, and HDL-tortuosity 284 
associations differed in males and females.  Reasons for these sex differences are unclear, 285 
but may relate to sex differences observed in retinal width-CHD associations, where 286 
associations are evident in women not men.13;31  Moreover, this study was novel in showing 287 
consistent metabolic associations with retinal vessel tortuosity, whereby increased venular 288 
tortuosity was associated with Type 2 diabetes risk factors (including levels of BMI and 289 
HbA1c), in addition to showing a strong association with prevalent Type 2 diabetes.  These 290 
associations persist after mutual adjustment, and exclusion of those with clinical diabetes, 291 
suggesting that these associations may be independent early markers of the disease 292 
process.  Associations observed in this study appear to contrast with those observed with 293 
overt disease, whereby arteriolar (not venular) tortuosity has been related to the duration 294 
of diabetes.32  Associations with Type 2 diabetes risk markers (including levels of BMI and 295 
HbA1c), as well as other cardiovascular risk factors (systolic blood pressure and blood 296 
cholesterol) were not observed amongst this diseased group.32  This may suggest 297 
differences in retinal vessel morphometry associations between disease development and 298 
overt disease. 299 
300 
Cross sectional and longitudinal associations between retinal vasculometry and CVD 301 
outcomes have been studied, including coronary heart disease (CHD), stroke and 302 
cardiovascular mortality.13;33-35  However, more recent evidence from prospective studies 303 
has raised some inconsistencies.  In particular, retinal vessel calibre changes are only 304 
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associated with CHD events in women not men,13;31 and in some studies vessel width 305 
associations with stroke appear only apparent in venules, which appears to contradict the 306 
perceived disease process.36  In the present study, we observed no association between 307 
retinal vascular width measures and prevalent CHD, although there was the suggestion of a 308 
positive association between arteriolar tortuosity and prevalent stroke, which was stronger 309 
after adjustment for age, sex and blood pressure.  An association between narrower 310 
arterioles and high blood pressure has been well documented.10;11;14;37  The present study 311 
confirms these findings, showing decreased arteriolar width associated with both increased 312 
systolic and diastolic blood pressure. 313 
Evidence examining associations between venular width and blood pressure have been less 314 
consistent,10 although a recent meta-analysis suggested increased width associated with 315 
hypertension.14  Our study showed a small but statistically significant decrease in venular 316 
width with increasing diastolic blood pressure, which remained after multivariable 317 
adjustment, although the magnitude of association was less than the association observed 318 
with arterioles.  This association was no longer statistically significant when those with 319 
prevalent cardiovascular disease and known / treated hypertension were excluded, but 320 
associations with systolic blood pressure remained.  The observation of an association 321 
between vessel width and systolic blood pressure amongst non-hypertensives, strengthens 322 
the potential additional use of retinal vessel morphometry assessment in routine health 323 
checks.  Of particular note were the different associations with vessel tortuosity, where 324 
increased arteriolar and venular tortuosity was associated with greater systolic blood 325 
pressure (but not diastolic blood pressure), while decreased venular tortuosity was 326 
associated with higher HDL.  The apparent different direction of associations with these 327 
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cardiovascular risk factors are potentially consistent, and replicate findings observed in one 328 
other large population based study.15329 
330 
By far the strongest associations observed were those with age and smoking, where per 331 
decade rise in age there was arteriolar narrowing and increased tortuosity, and with current 332 
smoking appreciable arteriolar and venular dilation.  There was also the suggestion of 333 
smaller arterioles and markedly greater tortuosity (both arteriolar and venular) in females 334 
compared to males.  However, sex differences in width were largely explained and 335 
differences in tortuosity partially explained by height (data not presented).  While 336 
differences in CVD risk between males and females may have contributed to these 337 
associations, explanations for potential sex differences in retinal vessel morphometry 338 
remain uncertain.  The effect of age was independent of blood pressure, as well as other 339 
cardiometabolic risk factors, but smaller compared to a body of literature suggesting a 2 to 340 
5µm decrease in arteriolar width per decade in age (although these later effect sizes were 341 
seen in relation to central retinal vessel equivalent sizes, which are 2-3 times larger as they 342 
are scaled-up from retinal measures taken within 0.5 to 1.5 disc diameters from the 343 
disc).10;38  Nevertheless, these observations demonstrate the well-known association 344 
between narrower more tortuous arterioles and older age.39  The vasodilatory effects of 345 
smoking have also been widely reported in venules, less so in arterioles.10  Increased carbon 346 
monoxide levels amongst smokers may well provide a biological explanation for these 347 
findings.40348 
349 
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Computerised assessment of vessels from retinal images have so far been heavily reliant on 350 
operator involvement, which is subjective, open to measurement error and time 351 
consuming,16 limiting its use in large population based studies.  The EPIC Eye study is such a 352 
study, which is richly phenotyped, allowing examination of multiple CVD risk factors within 353 
the same cohort.  Our fully automated system provides a rapid, detailed quantification of 354 
retinal vasculature in this population, for both arterioles and venules separately, since they 355 
show some opposing patterns of association with risk markers and disease states.41  The 356 
system has been extensively validated, and was successful in obtaining vessel measures in 4 357 
out of five who underwent retinal imaging.  It was not possible to obtain useful data from 358 
the remainder, as image quality was graded as insufficient (with the AV detection program 359 
unable to distinguish arterioles from venules), with images being decentred, defocussed, or 360 
obstructed by media opacities or lashes; an inevitable consequence of non-mydriasis, 361 
especially in this older age group.  This did not appear to reflect a selection bias, as there 362 
was no evidence of a marked differences in other phenotypes between those with and 363 
without vessel measures.  While those participating in the 3HC did appear to be select 364 
(being significantly younger, with higher BMI and of more privileged socioeconomic status 365 
compared to participants at baseline), this is unlikely to invalidate retinal vessel 366 
morphometry and cardiometabolic risk factor associations.42367 
368 
Our image analysis system has improved performance or is similar to earlier approaches,43-46369 
obtaining measures from the whole retinal image, not just concentric areas centred on the 370 
disc.10  Earlier studies have considered effect sizes in relation to central retinal artery and 371 
central retinal vein equivalents (CRAE, CRVE).10  It was not possible to directly compare 372 
measures with CRAE and CRVE, as the number of measures of width were considerably 373 
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more and located over the entire image.  Reducing the measurement area, typically 374 
between 0.5 to 1.5 disc diameters, to provide these measures would result in a huge data 375 
reduction, which might exclude vessel changes occurring elsewhere in the retina.  376 
Moreover, poor agreement between different systems has been highlighted, making direct 377 
comparisons in retinal calibre measures between systems problematic.47  Despite this we 378 
report similar effect sizes (e.g., the change in vessel width associated with smoking) in 379 
relation to a narrower mean width indicative of a far greater measurement area.  Vessel 380 
density is not uniform across the retina.48  Supplemental Figure 3 shows the extent of vessel 381 
measures in a typical image.  While the measures are not constrained to concentric areas 382 
close to the disc, as used in comparable systems,47 this was not perceived as a weakness 383 
given that our system is fully automated and does not allow for measurement areas to be 384 
selected.  Moreover, consistent inclusivity of measures across the whole image was 385 
observed in all images that were automatically selected as being of sufficient quality for 386 
inclusion, limiting any potential selection effects.19  Our approach is further supported by 387 
the first paper examining use of artificial intelligence (AI) in detecting cardiovascular 388 
disease, which appears to show that retinal vessels over their entire length are key areas of 389 
interest in estimating cardiovascular risk factors, such as age, blood pressure and HbA1c.49390 
While it is difficult at present to get precise information on how AI algorithms arrive at 391 
decisions, these findings suggest that retinal vasculometry studies, such as ours, are key to 392 
understanding processes associated with cardiometabolic disease. 393 
394 
We have condensed these measures to provide an overall summary of mean width, but it is 395 
possible that relative changes in vessel indices over time and perhaps variations in measures 396 
along the length of a vessel may be stronger predictors of vascular health than absolute size, 397 
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although this remains to be established.  The presence of differential retinal vasculometry 398 
associations with cardiometabolc risk factors underline the importance of making separate 399 
arteriolar and venular width and tortuosity measures, calling into question the validity of 400 
arteriolar / venular ratio measures for cardiovascular risk profiling. 401 
402 
The modest vasculometry association with prevalent stroke and the absence of associations 403 
with prevalent MI does not necessarily mean that retinal vasculometry measures are 404 
unlikely to have a role in CVD risk prediction.  Prevalent cases are likely to be very different 405 
to premorbid incident cases, with established cases often receiving vasoactive medications, 406 
which might have a modifying effect on vascular morphometry.  It is also possible that there 407 
was insufficient power to determine change in these dichotomous outcomes, given the 408 
small number of prevalent events within this study population.  However, retinal vessel 409 
associations with Type 2 diabetes risk markers and diabetes mellitus were observed, even 410 
after exclusion of those with prevalent outcome, suggesting that pre-clinical vasculometry 411 
changes are apparent.  This is commensurate with recent longitudinal evidence, raising the 412 
possibility that retinal vasculometry may have a role in risk prediction),50 as well as 413 
surveillance and disease management.  Power to determine change in continuous outcomes 414 
was greater, replicating previous observations and yielding a number of novel associations, 415 
particularly those with vessel tortuosity, as well as metabolic markers.  However, given the 416 
cross-sectional nature of data collection, these associations between cardiometabolic risk 417 
factors and retinal vessel abnormalities do not of themselves allow the potential role of 418 
retinal vessel quantification in disease risk prediction to be formally ascertained; future 419 
follow-up of this and other large cohorts with high quality retinal imaging data will allow this 420 
issue to be investigated. 421 
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FIGURE LEGENDS 
Figure 1:  Adjusted mean vessel width and tortuosity by quintiles of cardiovascular and Type 
2 diabetes risk factors, for venues and arterioles. Adjusted means (solid square symbols), 
95% CIs (error bars), regression lines (solid line) and associated 95% CIs (dashed lines) are 
from a multilevel model allowing for age, sex and repeated measure of vessel indices within 
person. 
Supplemental Figure 1:  Flow diagram of participant recruitment for different phases of the 
European Prospective Investigation of Cancer in Norfolk study, and in particular the third 
follow-up which included an eye examination. 
Supplemental Figure 2:  Histogram of arteriolar and venular width and tortuosity measures 
(including with and without log transformation for tortuosity measures). 
Supplemental Figure 3:  Automated arteriolar (red) and venular (blue) width measures 
recorded in one EPIC Eye image. 
Table 1.  Participant characteristics of EPIC participants who took part in the 3rd health check 
with and without useable fundus images (5947 versus 2676 participants) 
Characteristic Third Health Examination
Included in the 
analyses 
Excluded from the 
analyses 
Number 5947 2676
Age (SD) years 67.6 (7.6) 71.3 (8.6)
Gender n (% Female) 3,393 (57) 1,365 (51)
Current smokers n (%) 267 (4.5) 107 (4.0)
Former smoker n (%) 2,628 (44) 1284 (48)
Height (cm) 166.4 (9.1) 166.2 (9.2)
Weight (Kg) 74.4 (14.3) 74.6 (14.0)
BMI (Kg/m²) 26.8 (4.3) 27.0 (4.2)
Systolic blood pressure (mmHg) 135.7 (16.6) 137.3 (16.8)
Diastolic blood pressure (mmHg) 78.4 (9.2) 77.9 (9.6)
Total cholesterol (mmol/L) 5.4 (1.1) 5.3 (1.1)
LDL cholesterol (mmol/L) 3.2 (1.0) 3.1 (1.0)
HDL cholesterol (mmol/L) 1.5 (0.4) 1.5 (0.4)
Triglycerides (mmol/L) 1.7 (0.9) 1.6 (0.9)
HbA1c (%) 5.8 (0.6) 5.9 (0.7)
HbA1c (mmol/mol) 40 41 
Prevalent MI n (%) 187 (3.1) 106 (4.0) 
Prevalent stroke n (%) 118 (2.0) 67 (2.5) 
Prevalent Type 2 diabetes n (%) 237 (4.0) 156 (5.8) 
Mean axial length (SD) mm 23.6 (1.2) 23.5 (1.2) 
Mean best vision sphere (SD)
dioptres 0.2 (2.2) 0.2 (2.3) 
Mean arteriolar width (SD) microns 74.8 (6.9) -
Mean venular width (SD) microns 88.4 (11.3) -
Arteriolar tortuosity x 1000* 4.2 (1.6) -
Venular tortuosity x1000* 3.3 (1.3) -
Mean (SD) or n (%) as indicated.  
* Geometric mean (SD) 
For participants included in the analyses extent of missing data is as follows:- 
Cholesterol missing data for 429 participants 
LDL Cholesterol missing data for 511 participants 
HDL Cholesterol missing data for 428 participants 
Triglycerides missing data for 429 participants 
HbA1c missing data for 498 participants 
1 
Table 2.  Difference in vessel width (m) and tortuosity (%) associated with Type 2 diabetes and CVD risk factors and outcomes for individual 
factors in multivariable regression model age and sex adjusted
Risk marker Difference in arteriolar width (95% CI) m
P-
value
Difference in venular 
width (95% CI) m 
P-
value 
Difference in arteriolar 
tortuosity (95% CI) % 
P-
value 
Difference in venular 
tortuosity (95% CI) % 
P-
value 
Per decade in age -0.79 (-1.00, -0.58) <0.001 2.56 (2.20, 2.91) <0.001 5.44 (3.80, 7.11) <0.001 -0.23 (-1.15, 0.69) 0.619
Female vs male -0.51 (-0.83, -0.19) 0.002 -0.32 (-0.86, 0.22) 0.245 3.83 (1.37, 6.35) 0.002 2.16 (0.74, 3.60) 0.003
Current vs never 
smoked 
2.13 (1.34, 2.91) <0.001 3.03 (1.71, 4.34) <0.001 -2.70 (-8.22, 3.16) 0.360 1.66 (-1.75, 5.18) 0.345
Former vs never 
smoked 
0.11 (-0.23, 0.44) 0.522 0.31 (-0.25, 0.87) 0.275 -0.21 (-2.67, 2.31) 0.870 0.88 (-0.58, 2.36) 0.240
Per 5 kg/m² in BMI 0.15 (-0.03, 0.34) 0.098 0.72 (0.41, 1.03) <0.001 -0.24 (-1.59, 1.13) 0.729 2.52 (1.71, 3.34) <0.001
Per 10mmHg in 
SBP 
-0.50 (-0.60, -0.41) <0.001 -0.06 (-0.23, 0.10) 0.458 1.20 (0.47, 1.94) 0.001 0.45 (0.02, 0.88) 0.039
Per 10mmHg in 
DBP 
-1.04 (-1.22, -0.87) <0.001 -0.32 (-0.61, -0.02) 0.035 0.75 (-0.56, 2.07) 0.263 -0.55 (-1.30, 0.21) 0.157
Per 1mmol/L in TC -0.18 (-0.33, -0.02) 0.024 -0.16 (-0.41, 0.10) 0.233 0.42 (-0.72, 1.58) 0.472 -0.52 (-1.18, 0.15) 0.131
Per 1mmol/L in 
LDL 
-0.09 (-0.26, 0.08) 0.313 -0.24 (-0.53, 0.05) 0.108 0.60 (-0.69, 1.90) 0.362 -0.39 (-1.14, 0.36) 0.310
Per 1mmol/L in 
HDL 
-1.18 (-1.62, -0.74) <0.001 -1.42 (-2.16, -0.69) <0.001 -0.61 (-3.82, 2.70) 0.714 -1.83 (-3.70, 0.07) 0.059
Per 1mmol/L in 
Triglycerides 
0.06 (-0.12, 0.23) 0.524 0.57 (0.27, 0.86) <0.001 0.29 (-1.01, 1.62) 0.661 -0.18 (-0.94, 0.59) 0.647
Per % in HbA1c per 0.22 (-0.08, 0.51) 0.148 0.41 (-0.07, 0.90) 0.097 0.95 (-1.21, 3.15) 0.393 2.24 (0.96, 3.53) 0.001
Prevalent MI vs 
absent 
0.66 (-0.27, 1.58) 0.165 1.20 (-0.35, 2.75) 0.129 4.36 (-2.57, 11.77) 0.224 1.87 (-2.14, 6.05) 0.366
Prevalent Stroke vs 
absent 
0.79 (-0.37, 1.95) 0.181 0.59 (-1.35, 2.53) 0.553 8.30 (-0.59, 17.99) 0.068 3.66 (-1.42, 9.01) 0.161
Prevalent DM vs 
absent 
-0.08 (-0.90, 0.75) 0.857 0.48 (-0.90, 1.86) 0.494 1.64 (-4.38, 8.03) 0.602 6.53 (2.78, 10.41) 0.001
2 
Number included n=5,942. Regression coefficients are from a multilevel model allowing for repeated images from the same person (random effect for person) and 
adjusting for age and sex as fixed effects.  Prevalent MI, stroke, DM (Diabetes Mellitus); n=187, 118, 238 respectively 
Cholesterol missing data for 429 participants 
LDL Cholesterol missing data for 511 participants 
HDL Cholesterol missing data for 428 participants 
Triglycerides missing data for 429 participants 
HbA1c missing data for 498 participants 
AGE 
BMI 
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